Friday , April 20 2018
Home / Letter From The Editor (page 40)

Letter From The Editor

Letter from the Editor, #759

This past Thursday I got to see just how good cyclists can be when they’re in competition. I had qualified for the Florida Senior Games and was in Cape Coral to attempt to qualify for the nationals in the 60-64 age group. The first race was 20K and, although I …

Read More »

Editor’s Note, DCMS #218

In our main newsletter last week we had an item about the effects of TZD’s on metabolism and the MEK/ERK pathway. Further research shows that there is also a lot of evidence that pioglitazone is cardioprotective. This week, in our Homerun Slides, Dr. Stanley Schwartz discusses how this TZD has been …

Read More »

Letter from the Editor, #758

It has been about five years since Dr. Steven Nissen started his public attack on the TZDs. His outspoken observations drove many prescribers away from using pioglitazone or rosiglitazone, and the FDA even agreed with his opinions, which drove the rest of us to stop using the medication all together. …

Read More »

Editor’s Note, DCMS #217

It appears that the weather this winter may turn out to be worse than last year’s. Even here in sunny St. Petersburg, Fla., I had to pull out the winter gear for cycling. During these cold times patients often complain about their feet hurting more than usual. This could be …

Read More »

Letter from the Editor, #757

When Walmart first introduced their $4 generic drug program we thought that it would be an oddity for a month or two and then go away. Then everyone jumped on the bandwagon and soon these programs were so commonplace that our patients felt anything over $4 was too much. Studies …

Read More »

Editor’s Note, DCMS #216

Every time we talk to a patient newly diagnosed with diabetes we talk about the kidneys, the feet, and the eyes, and what can happen if we let our glucose levels run rampant. We focus on this because the concept of microvascular complications has been beaten into our heads since …

Read More »

Letter from the Editor, #756

When the first gastric bypass was done, the incision was about 6-9 inches long. Then came lap band surgery for weight loss. We have gone from 4 incisions to one small incision over the past five years. We are always looking for less-invasive ways to help our patients lose weight …

Read More »

Editor’s Note, DCMS #215

A little over five years ago, a small company came to market with a low-dose rapid-acting dopamine receptor agonist with a claim that it could reset metabolism endpoints in the neuroendocrine system. Soon as prescribers heard the word “dopamine,” red flags went up and prescribing has gone nowhere. This week …

Read More »